The Doctor’s Advocate | Third Quarter 2023
Foundation News

Spotlight on Foundation Grants: Michigan Medicine, University of Michigan

In 2022, The Doctors Company Foundation sponsored Michigan Medicine’s eXtended Reality (XR) Procedural Simulation curricula, a project that enhances learning outcomes through augmented reality technology.

Authors Taylor Kantor, MD; Rishindra Reddy, MD, MBA; and Deb Lee, PhD, RN, FNP, report that preliminary data from the University of Michigan School of Nursing show promise in developing XR procedural simulation for common bedside procedures. The program’s clinical effects include improving procedural efficiency, enhancing engagement, increasing usability of the simulation environment, and boosting procedure safety—all while reducing faculty time and effort and maintaining 100 percent procedural competency ratings.

The curriculum’s initial phase includes developing a custom XR central line insertion guide to reduce central line–associated bloodstream infection events. Future developments will include dozens of bedside procedures with the goal of altering the training environment and developing a new gold standard for procedural simulation.

Learn more about the Foundation’s work to fund patient safety research, education, and training to improve clinical outcomes.

The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.

The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.

The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider considering the circumstances of the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.

The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.